Perampanel Tablet, Film Coated
Product Images NDC 51672-4208

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Perampanel (NDC 51672-4208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label (Rx525784200l30 Sun19a 10 mg)

Perampanel 10 mg film-coated oral tablets label from Sun Pharmaceutical Industries, Inc. The label indicates prescription use with a 30-tablet count. Storage instructions specify 20° to 25°C (68° to 77°F). Manufacturer is Taro Pharmaceutical Industries Ltd., Israel, with distribution by Sun Pharmaceutical Industries, Inc., Cranbury, NJ. Includes pharmacist dispensing instructions and NDC number 51672-4208-6.*

FDA Label Image

Container Label (Rx525784300l30 Sun19a 12 mg)

Label for Perampanel 12 mg film-coated tablets by Sun Pharmaceutical Industries, Inc. The label indicates 30 tablets per package, with storage instructions at 20° to 25°C, and includes a barcode and manufacturer details from Taro Pharmaceutical Industries Ltd., Israel. It specifies dispensing the accompanying Medication Guide and keeping medications out of children's reach.*

FDA Label Image

Container Label (Rx525784400l30 Sun19a 4 mg)

Label for Perampanel tablets 4 mg film-coated oral tablets produced by Sun Pharmaceutical Industries, Inc. The label includes NDC 51672-4205-6 and states a package quantity of 30 tablets. It features storage instructions and cautions, and a barcode is visible on the right side.*

FDA Label Image

Container Label (Rx525784500l30 Sun19a 6 mg)

Perampanel 6 mg film-coated tablets label from Sun Pharmaceutical Industries, Inc. The label includes the NDC 51672-4206-6, directions to dispense the Medication Guide to each patient, and states the package contains 30 tablets. Manufacturer is Taro Pharmaceutical Industries Ltd., Israel, with distribution by Sun Pharmaceutical Industries, Inc., Cranbury, NJ. Storage instructions and warnings about keeping out of reach of children are included.*

FDA Label Image

Container Label (Rx525793200l30 Sun19a 8 mg)

Perampanel 8 mg film-coated tablets label shows the branded and generic name, strength 8 mg, and quantity of 30 tablets. The label includes a note for pharmacists to dispense the medication guide, storage instructions at 20° to 25°C, and manufacturer information: Taro Pharmaceutical Industries Ltd. and distributor Sun Pharmaceutical Industries, Inc. A barcode is visible on the right side of the label.*

FDA Label Image

Container Label (Rx525793600l30 Sun19a 2 mg)

Label for Perampanel 2 mg film-coated tablets, a human prescription drug for oral use. Label includes dosage strength (2 mg) and packaging quantity (30 tablets). It carries instructions for pharmacists to dispense accompanying medication guides, storage conditions at 20° to 25°C, and manufacturer information: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel, distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ. A barcode and NDC 51672-4204-6 are also shown.*

FDA Label Image

Chemical Structure (Perampanel 01)

Chemical structure of Perampanel, showing its molecular framework including pyridine, phenyl, and cyano functional groups, with notation indicating 3/4 hydrate (3/4 H2O).*

FDA Label Image

Figure 1 (Perampanel 02)

A bar chart displaying median percentage reduction in seizure frequency from baseline across three studies comparing placebo and Perampanel at various doses (4 mg, 8 mg, 12 mg). The chart presents seizure reduction on the y-axis and dosing groups on the x-axis, highlighting greater seizure reduction with Perampanel doses than placebo.*

FDA Label Image

Figure 2 (Perampanel 03)

A bar chart comparing the proportion of patients (%) experiencing different ranges of outcome measures across four groups: placebo, Perampanel 4 mg/day, Perampanel 8 mg/day, and Perampanel 12 mg/day. The categories on the x-axis represent ranges from 'Worse' to '75 to 100,' showing patient distribution within these outcome intervals.*

FDA Label Image

Figure 3 (Perampanel 04)

A bar graph comparing the proportion of patients (percentage) between placebo and perampanel treatment groups across five outcome categories: Worse, 0 to <25, 25 to <50, 50 to <75, and 75 to 100. Each treatment group consists of 81 patients. The graph shows patient distribution percentages for each category by treatment group with perampanel represented by shaded bars and placebo by solid bars.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.